Charles River Laboratories Publishes 2023 Corporate Citizenship Report
2024年3月27日 - 9:00PM
ビジネスワイヤ(英語)
ESG progress includes $200M investment in
alternative testing methods; achievement of 92% renewable energy
usage worldwide
Charles River Laboratories International, Inc. (NYSE: CRL) today
announced the publication of its 2023 Corporate Citizenship Report,
which includes progress and results from 2022 and 2023. The 2023
report demonstrates Charles River’s priorities and commitments
across its strategic Environmental, Social and Governance (ESG)
areas of focus: Accelerate Life-Saving Therapies; Lead with
Integrity; Inspire our People; and Protect our Planet.
“The work we do at Charles River today extends beyond science.
With more than 21,000 employees, our collective efforts are
powerful, and our influence is transforming the biopharmaceutical
industry to make a difference for both patients and the planet,”
said James C. Foster, Chair, President, and Chief Executive Officer
of Charles River. “We are proud of the progress we have made on our
ESG commitments while working together to develop treatments that
can save lives.”
Published every two years, the report highlights Charles River’s
progress towards its ambitious Corporate Citizenship goals, as well
as new milestones and accomplishments:
Accelerate Life-Saving Therapies
Charles River is committed to bringing effective medicines to
patients safely and as quickly as possible and continues to be a
trusted, global scientific partner of choice:
- Worked on 80% of the drugs approved by the U.S. Food and Drug
Administration (FDA) in the past five years (2019-2023) and 85% of
the drugs approved by the FDA in 2023 alone.
- Invested more than $4.5 billion in strategic acquisitions since
2012 to ensure clients have access to emerging therapies and
technologies that help bring safe, effective treatments to market
faster.
- Launched the Apollo™ technology solution, providing clients
with access to an industry-leading, secure, cloud-based platform
housing study data, study milestones, documents, cost estimates,
and program planning tools.
Lead with Integrity
Making a positive impact on patients, animals in its care, and
communities where employees work is central to Charles River’s
ethos. During the 2022-2023 period, the Company:
- Established a Responsible Animal Use Committee of the Company's
Board of Directors and the Office for Responsible Animal Usage
(ORAU) to oversee responsible animal utilization and reduction
practices, and operating standards of care.
- Further demonstrated its commitment to the 3Rs Principle –
Replacement, Reduction, and Refinement – by spearheading the
addition of a foundational fourth R, Responsibility – ultimately
establishing the 4Rs to bring renewed focus to its commitment to
animal welfare.
- Became a signatory to the United Nations Global Compact
(UNGC).
- Received ISO 27001 certification, the international standard
for information security management systems (ISMS), in 2023.
Inspire our People
Charles River is committed to providing an exceptional employee
experience in which its people can learn, grow, and make an impact.
Employee-focused initiatives include:
- Grew 11 Employee Resource Groups (ERGs) to include nearly 4,000
people, helping to cultivate a sense of belonging and
inclusion.
- Demonstrated the Company’s commitment to equity by advancing
women in leadership, with women representing 53% of total
leadership in 2023 and the composition of women at the Executive
Leadership level (VP+) increasing to 42% in 2023.
- Remained focused on employee learning and development as
employees globally completed more than 410,000 learning
sessions.
- Contributed a total of 29,000 employee volunteer hours in 2023,
a company record.
Protect our Planet
Charles River operates responsibly and promotes a sustainable
future in the communities where the Company operates. Working
towards its environmental goals, Charles River:
- Reduced Scope 1 and 2 global greenhouse gas (GHG) emissions by
37% over the last five years, targeting a 50% reduction by
2030.
- Achieved 92% renewable electricity usage globally, working
toward the deployment of 100% renewable electricity across
operations by 2030.
- Continued advancing global sustainability capital projects
through its annual Sustainability Capital Fund, originally
introduced in 2020. As of year-end 2023, the fund has supported
$13.5 million in projects.
The 2023 Corporate Citizenship Report was prepared in accordance
with the latest Global Reporting Initiative (GRI) Universal
Standards, as well as the Sustainability Accounting Standards Board
(SASB) Biotechnology and Pharmaceuticals Standard. The report is
also aligned with relevant U.N. Sustainable Development Goals
(UNSDGs) and recommendations set out by the Task Force on
Climate-related Financial Disclosures (TCFD). The TCFD report will
be available later in 2024 at www.criver.com.
Visit the Corporate Citizenship section of Charles River’s
website to read the 2023 Corporate Citizenship Report in its
entirety and learn more about the Company’s ESG disclosures.
About Charles River
Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their
research and drug development efforts. Our dedicated employees are
focused on providing clients with exactly what they need to improve
and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services,
visit www.criver.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240327700198/en/
Charles River Investor Contact: Todd Spencer Corporate
Vice President, Investor Relations 781.222.6455
todd.spencer@crl.com
Charles River Media Contact: Amy Cianciaruso Corporate
Vice President, Chief Communications Officer 781.222.6168
amy.cianciaruso@crl.com
Charles River Laboratories (NYSE:CRL)
過去 株価チャート
から 4 2024 まで 5 2024
Charles River Laboratories (NYSE:CRL)
過去 株価チャート
から 5 2023 まで 5 2024